HIgh Flow Versus NIV for Acute Cardiogenic PuLmonary Oedema With Acute Respiratory Failure in an ED

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 22, 2021

Primary Completion Date

November 1, 2022

Study Completion Date

December 1, 2022

Conditions

Cardiogenic Pulmonary Edema

Interventions

DEVICE

Non invasive ventilation

Emergency and transport ventilator (Monnal T60, Airliquide, Antony, France)

DEVICE

High-flow nasal cannula heated and humidified oxygen

AirVO2 device (Fisher and Paykel, New Zealand)

Trial Locations (1)

CHU Poitiers, Poitiers

All Listed Sponsors

lead

Poitiers University Hospital

OTHER

NCT04971213 - HIgh Flow Versus NIV for Acute Cardiogenic PuLmonary Oedema With Acute Respiratory Failure in an ED | Biotech Hunter | Biotech Hunter